Brown Mitchell, Eardley Stephanie, Ahmad Jamil, Lista Frank, Barr Scott, Mulholland Stephen, Khanna Julie, Knapp Charles, Saheb-Al-Zamani Maryam, Austin Ryan, Levine Ronald
Department of Surgery, University of Toronto, Toronto, Canada.
Toronto Plastic Surgery, Toronto, Canada.
Aesthet Surg J. 2021 Oct 15;41(11):NP1427-NP1433. doi: 10.1093/asj/sjaa311.
On March 11, 2020, the World Health Organization declared the novel Coronavirus-19 (COVID-19) a worldwide pandemic, resulting in an unprecedented shift in the Canadian healthcare system, where protection of an already overloaded system became a priority; all elective surgeries and non-essential activities were ceased. With the impact being less than predicted, on May 26, 2020, elective surgeries and non-essential activities were permitted to resume.
The authors sought to examine outcomes following elective aesthetic surgery and the impact on the Canadian healthcare system with the resumption of these services during the COVID-19 worldwide pandemic.
Data were collected in a prospective manner on consecutive patients who underwent elective plastic surgery procedures in 6 accredited ambulatory surgery facilities. Data included patient demographics, procedural characteristics, COVID-19 polymerase chain reaction (PCR) test status, airway management, and postoperative outcomes.
A total of 368 patients underwent elective surgical procedures requiring a general anesthetic. All 368 patients who underwent surgery were negative on pre-visit screening. A COVID-19 PCR test was completed by 352 patients (95.7%) and all were negative. In the postoperative period, 7 patients (1.9%) had complications, 3 patients (0.8%) required a hospital visit, and 1 patient (0.3%) required hospital admission. No patients or healthcare providers developed COVID-19 symptoms or had a positive test for COVID-19 within 30 days of surgery.
With appropriate screening and safety precautions, elective aesthetic plastic surgery can be performed in a manner that is safe for patients and healthcare providers and with a very low risk for accelerating virus transmission within the community.
2020年3月11日，世界卫生组织宣布新型冠状病毒肺炎（COVID-19）为全球大流行病，这导致加拿大医疗系统发生了前所未有的转变，保护本已不堪重负的系统成为首要任务；所有择期手术和非必要活动均被暂停。由于影响小于预期，2020年5月26日，择期手术和非必要活动被允许恢复。
作者试图研究择期美容手术的结果以及在COVID-19全球大流行期间恢复这些服务对加拿大医疗系统的影响。
前瞻性收集在6家经认可的门诊手术机构接受择期整形手术的连续患者的数据。数据包括患者人口统计学信息、手术特征、COVID-19聚合酶链反应（PCR）检测状态、气道管理和术后结果。
共有368例患者接受了需要全身麻醉的择期手术。所有接受手术的368例患者在术前筛查时均为阴性。352例患者（95.7%）完成了COVID-19 PCR检测，结果均为阴性。术后，7例患者（1.9%）出现并发症，3例患者（0.8%）需要就医，1例患者（0.3%）需要住院。在术后30天内，没有患者或医护人员出现COVID-19症状或COVID-19检测呈阳性。
通过适当的筛查和安全预防措施，择期美容整形手术可以以对患者和医护人员安全的方式进行，且在社区内加速病毒传播的风险非常低。
